Cite
APA Citation
Rolfes, L., Pawlitzki, M., Pfeuffer, S., Nelke, C., Lux, A., Pul, R., Kleinschnitz, C., Kleinschnitz, K., Rogall, R., Pape, K., Bittner, S., Zipp, F., Warnke, C., Goereci, Y., Schroeter, M., Ingwersen, J., Aktas, O., Klotz, L., Ruck, T., Wiendl, H., & Meuth, S. G. (2021). ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19. Neurology, 8(5), . http://access.bl.uk/ark:/81055/vdc_100146089040.0x000005